Putnam Investments’s Castle Biosciences CSTL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q4
$540K Sell
25,006
-789
-3% -$17K ﹤0.01% 922
2023
Q3
$436K Buy
25,795
+10,283
+66% +$174K ﹤0.01% 942
2023
Q2
$213K Buy
15,512
+1,056
+7% +$14.5K ﹤0.01% 1127
2023
Q1
$328K Buy
14,456
+5,739
+66% +$130K ﹤0.01% 1071
2022
Q4
$205K Buy
+8,717
New +$205K ﹤0.01% 1114
2022
Q1
Sell
-77,152
Closed -$3.31M 1194
2021
Q4
$3.31M Buy
77,152
+5,833
+8% +$250K ﹤0.01% 671
2021
Q3
$4.74M Sell
71,319
-17
-0% -$1.13K 0.01% 537
2021
Q2
$5.23M Buy
71,336
+2,474
+4% +$181K 0.01% 506
2021
Q1
$4.72M Sell
68,862
-13,953
-17% -$955K 0.01% 509
2020
Q4
$5.56M Buy
82,815
+11,138
+16% +$748K 0.01% 479
2020
Q3
$3.69M Sell
71,677
-120
-0.2% -$6.17K 0.01% 532
2020
Q2
$2.71M Buy
71,797
+17,898
+33% +$675K 0.01% 599
2020
Q1
$1.61M Buy
+53,899
New +$1.61M ﹤0.01% 661